Your browser doesn't support javascript.
loading
Development of a long-acting direct-acting antiviral system for hepatitis C virus treatment in swine.
Verma, Malvika; Chu, Jacqueline N; Salama, John A F; Faiz, Mohammed T; Eweje, Feyisope; Gwynne, Declan; Lopes, Aaron; Hess, Kaitlyn; Soares, Vance; Steiger, Christoph; McManus, Rebecca; Koeppen, Ryan; Hua, Tiffany; Hayward, Alison; Collins, Joy; Tamang, Siddartha M; Ishida, Keiko; Miller, Jonathan B; Katz, Stephanie; Slocum, Alexander H; Sulkowski, Mark S; Thomas, David L; Langer, Robert; Traverso, Giovanni.
Affiliation
  • Verma M; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139.
  • Chu JN; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139.
  • Salama JAF; Tata Center for Technology and Design, Massachusetts Institute of Technology, Cambridge, MA 02139.
  • Faiz MT; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139.
  • Eweje F; Division of Gastroenterology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114.
  • Gwynne D; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139.
  • Lopes A; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139.
  • Hess K; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139.
  • Soares V; Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139.
  • Steiger C; Division of Gastroenterology, Hepatology, and Endoscopy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115.
  • McManus R; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139.
  • Koeppen R; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139.
  • Hua T; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139.
  • Hayward A; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139.
  • Collins J; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139.
  • Tamang SM; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139.
  • Ishida K; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139.
  • Miller JB; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139.
  • Katz S; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139.
  • Slocum AH; Division of Gastroenterology, Hepatology, and Endoscopy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115.
  • Sulkowski MS; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139.
  • Thomas DL; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139.
  • Langer R; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139.
  • Traverso G; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139.
Proc Natl Acad Sci U S A ; 117(22): 11987-11994, 2020 06 02.
Article in En | MEDLINE | ID: mdl-32424082

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Drug Delivery Systems / Hepatitis C, Chronic Limits: Animals Language: En Journal: Proc Natl Acad Sci U S A Year: 2020 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Drug Delivery Systems / Hepatitis C, Chronic Limits: Animals Language: En Journal: Proc Natl Acad Sci U S A Year: 2020 Type: Article